Join to view full profile
450 Brookline AvenueDana Farber Cancer InsituteBoston, MA 02115
Phone+1 617-632-2166
Fax+1 617-632-4773
Dr. Lee is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
WashU MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2026 - 2028
MA State Medical License 2007 - 2026
ME State Medical License 2022 - 2026
NH State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
RI State Medical License 2020 - 2020
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
Clinical Trials
- A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
- Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2014 Jul 02
- A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Publications & Presentations
PubMed
- Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma.Vihang Nakhate, Aleksandra B Lasica, Loai Aker, Julie J Miller, Ian Pan
Neuro-Oncology. 2026-10-16 - 1 citationsBreaking barriers in leptomeningeal disease: A Society for Neuro-Oncology and The American Society of Clinical Oncology consensus review on clinical trial design and b...Yolanda Piña, Maxine Umeh Garcia, Adrienne Boire, Andrew Brenner, David Ross Camidge
Neuro-Oncology. 2026-10-01 - Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial.Lu Sun, Lauren F Markus, Julio C Sanchez, Thomas J Lai, Eudocia Quant Lee
Nature Communications. 2026-09-05
Lectures
- Barriers to accrual and enrollment in brain tumor trials.2019 ASCO Annual Meeting - 6/1/2019
Other
- Anticoagulant and antiplatelet therapy in patients with brain tumorsLee EQ, Wen PY
http://www.uptodate.com/contents/anticoagulant-and-antiplatelet-therapy-in-patients-with-brain-tumor
UpToDate, Wolters Kluwer Health - 2013-02-22 - Neurologic complications of cancer treatment with biologic agentsLee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-cancer-treatment-with-biologic-agents
UpToDate, Wolters Kluwer Health - 2013-02-25 - Neurologic complications of non-platinum cancer chemotherapyLee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-non-platinum-cancer-chemotherapy
UpToDate, Wolters Kluwer Health - 2013-03-19
Press Mentions
EMBARGOED: Study Reveals Activity of Navtemadlin in Glioblastoma, Points to Possible Treatment ImprovementsFebruary 19th, 2025- Kazia Executes Agreement to Commence GBM Agile Pivotal StudyOctober 16th, 2020
- Kazia Therapeutics Executes Agreement to Begin GBM Agile Pivotal StudyOctober 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: